Literature DB >> 25728834

Memories reactivated under ketamine are subsequently stronger: A potential pre-clinical behavioral model of psychosis.

Michael J Honsberger1, Jane R Taylor1, Philip R Corlett1.   

Abstract

BACKGROUND: Sub-anesthetic doses of the NMDA antagonist ketamine have been shown to model the formation and stability of delusion in human subjects. The latter has been predicted to be due to aberrant prediction error resulting in enhanced destabilization of beliefs. To extend the scope of this model, we investigated the effect of administration of low dose systemic ketamine on memory in a rodent model of memory reconsolidation.
METHODS: Systemic ketamine was administered either prior to or immediately following auditory fear memory reactivation in rats. Memory strength was assessed by measuring freezing behavior 24h later. Follow up experiments were designed to investigate an effect of pre-reactivation ketamine on short-term memory (STM), closely related memories, and basolateral amygdala (BLA) specific destabilization mechanisms.
RESULTS: Rats given pre-reactivation, but not post-reactivation, ketamine showed larger freezing responses 24h later compared to vehicle. This enhancement was not observed 3h after the memory reactivation, nor was it seen in a closely related contextual memory. Prior inhibition of a known destabilization mechanism in the BLA blocked the effect of pre-reactivation ketamine.
CONCLUSIONS: Pre- but not post-reactivation ketamine enhances fear memory. These data together with recent data in human subjects supports a model of delusion fixity that proposes that aberrant prediction errors result in enhanced destabilization and strengthening of delusional belief.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fear conditioning; Ketamine; Reconsolidation; Schizophrenia

Mesh:

Substances:

Year:  2015        PMID: 25728834      PMCID: PMC4409515          DOI: 10.1016/j.schres.2015.02.009

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  71 in total

1.  Treatment refractory schizophrenia.

Authors:  J P Lindenmayer
Journal:  Psychiatr Q       Date:  2000

2.  Complementary roles for amygdala and periaqueductal gray in temporal-difference fear learning.

Authors:  Sindy Cole; Gavan P McNally
Journal:  Learn Mem       Date:  2008-12-30       Impact factor: 2.460

3.  Memantine facilitates memory consolidation and reconsolidation in the day-old chick.

Authors:  Jodi R Samartgis; Leslie Schachte; Agnes Hazi; Simon F Crowe
Journal:  Neurobiol Learn Mem       Date:  2012-03-07       Impact factor: 2.877

Review 4.  Ifenprodil, a novel NMDA receptor antagonist: site and mechanism of action.

Authors:  K Williams
Journal:  Curr Drug Targets       Date:  2001-09       Impact factor: 3.465

5.  Repetition is good? An Internet trial on the illusory truth effect in schizophrenia and nonclinical participants.

Authors:  Steffen Moritz; Ulf Köther; Todd S Woodward; Ruth Veckenstedt; Alice Dechêne; Christoph Stahl
Journal:  J Behav Ther Exp Psychiatry       Date:  2012-05-08

6.  Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

Authors:  B Moghaddam; B Adams; A Verma; D Daly
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

7.  NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex.

Authors:  Mark E Jackson; Houman Homayoun; Bita Moghaddam
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-24       Impact factor: 11.205

8.  GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.

Authors:  Jeffrey Burgdorf; Xiao-lei Zhang; Katherine L Nicholson; Robert L Balster; J David Leander; Patric K Stanton; Amanda L Gross; Roger A Kroes; Joseph R Moskal
Journal:  Neuropsychopharmacology       Date:  2012-12-05       Impact factor: 7.853

9.  Independent cellular processes for hippocampal memory consolidation and reconsolidation.

Authors:  Jonathan L C Lee; Barry J Everitt; Kerrie L Thomas
Journal:  Science       Date:  2004-04-08       Impact factor: 47.728

Review 10.  Schizophrenia, ketamine and cannabis: evidence of overlapping memory deficits.

Authors:  Paul C Fletcher; Garry D Honey
Journal:  Trends Cogn Sci       Date:  2006-03-10       Impact factor: 20.229

View more
  16 in total

Review 1.  Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine.

Authors:  Liana Fattore; Alessandro Piva; Mary Tresa Zanda; Guido Fumagalli; Cristiano Chiamulera
Journal:  Psychopharmacology (Berl)       Date:  2017-11-25       Impact factor: 4.530

Review 2.  Reconsolidation and psychopathology: Moving towards reconsolidation-based treatments.

Authors:  Amber B Dunbar; Jane R Taylor
Journal:  Neurobiol Learn Mem       Date:  2016-11-09       Impact factor: 2.877

3.  Prophylactic Ketamine Attenuates Learned Fear.

Authors:  Josephine C McGowan; Christina T LaGamma; Sean C Lim; Melina Tsitsiklis; Yuval Neria; Rebecca A Brachman; Christine A Denny
Journal:  Neuropsychopharmacology       Date:  2017-01-27       Impact factor: 7.853

4.  Effects of systemic glutamatergic manipulations on conditioned eyeblink responses and hyperarousal in a rabbit model of post-traumatic stress disorder.

Authors:  Lauren B Burhans; Carrie A Smith-Bell; Bernard G Schreurs
Journal:  Behav Pharmacol       Date:  2017-10       Impact factor: 2.293

Review 5.  Explaining Delusions: Reducing Uncertainty Through Basic and Computational Neuroscience.

Authors:  Erin J Feeney; Stephanie M Groman; Jane R Taylor; Philip R Corlett
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

6.  Targeted effects of ketamine on perceptual expectation during mediated learning in rats.

Authors:  Leah M Fleming; Frances-Julia B Jaynes; Summer L Thompson; Philip R Corlett; Jane R Taylor
Journal:  Psychopharmacology (Berl)       Date:  2022-04-07       Impact factor: 4.415

7.  Prediction of individual differences in fear response by novelty seeking, and disruption of contextual fear memory reconsolidation by ketamine.

Authors:  Florian Duclot; Iara Perez-Taboada; Katherine N Wright; Mohamed Kabbaj
Journal:  Neuropharmacology       Date:  2016-06-22       Impact factor: 5.250

8.  Ventral CA3 Activation Mediates Prophylactic Ketamine Efficacy Against Stress-Induced Depressive-like Behavior.

Authors:  Alessia Mastrodonato; Randy Martinez; Ina P Pavlova; Christina T LaGamma; Rebecca A Brachman; Alfred J Robison; Christine A Denny
Journal:  Biol Psychiatry       Date:  2018-02-23       Impact factor: 13.382

9.  Targeted neural network interventions for auditory hallucinations: Can TMS inform DBS?

Authors:  Joseph J Taylor; John H Krystal; Deepak C D'Souza; Jason Lee Gerrard; Philip R Corlett
Journal:  Schizophr Res       Date:  2017-09-29       Impact factor: 4.939

Review 10.  Prediction error, ketamine and psychosis: An updated model.

Authors:  Philip R Corlett; Garry D Honey; Paul C Fletcher
Journal:  J Psychopharmacol       Date:  2016-05-25       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.